Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
0.100
-0.019 (-15.97%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China.
The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms.
It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.
The company serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Haoxi Health Technology Limited
| Country | China |
| Founded | 2018 |
| IPO Date | Jan 26, 2024 |
| Industry | Advertising Agencies |
| Sector | Communication Services |
| Employees | 30 |
| CEO | Zhen Fan |
Contact Details
Address: Tower C, Building 103, Floor 8, Room 801 Chaoyang, 100000 China | |
| Phone | 86 10 13311 587976 |
| Website | haoximedia.com |
Stock Details
| Ticker Symbol | HAO |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001954594 |
| CUSIP Number | 73936Q629 |
| ISIN Number | KYG4290F1000 |
| SIC Code | 7311 |
Key Executives
| Name | Position |
|---|---|
| Zhen Fan | Chairman and Chief Executive Officer |
| Lei Xu | Founder, Chief Compliance Officer, Chief Operating Officer and Director |
| Yu Guo | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 19, 2024 | 6-K | Report of foreign issuer |
| Nov 27, 2024 | 6-K | Report of foreign issuer |
| Nov 6, 2024 | 6-K | Report of foreign issuer |
| Oct 29, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Sep 25, 2024 | 6-K | Report of foreign issuer |
| Sep 23, 2024 | 6-K | Report of foreign issuer |
| Sep 20, 2024 | 424B4 | Prospectus |
| Sep 19, 2024 | EFFECT | Notice of Effectiveness |
| Sep 19, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 12, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |